Adcetris: An encapsulated information Adcetris is an FDA-approved medicine. Brentuximab Vedotin is the active ingredient in medicine which is an ADC. The antibody is a chimeric IgG1 directed against CD30. Healthcare professionals use this medicine in treating patients with: Hodgkin lymphoma (HL), also called Hodgkin's disease, is a type of cancer that develops in the lymph system. Your lymph system is part of your immune system. It helps protect your body from infection and disease. Systemic anaplastic large cell lymphoma (sALCL) is a rare type of blood cancer that occurs in white blood cells. This medicine is available in 50 mg in single-use vials to administer intravenously. Healthcare professionals should administer Adcetris 50 mg injection as an intravenous infusion over 30 minutes every 3 weeks until disease progression or unacceptable toxicity. One should not mix Adcetris with or administer it as an infusion with other medicinal products. Adcetris side-effects of are: • • • • • • • • • • • • • • • •
Peripheral neuropathy Fatigue Nausea Diarrhea Neutropenia upper respiratory tract infection Pyrexia Constipation Vomiting Alopecia Decreased weight Abdominal pain Anemia Stomatitis Lymphopenia Mucositis
Brentuximab Vedotin Injection is supplied as a sterile, white to off-white preservative-free lyophilized cake or powder in individually-boxed single-use vials. One should store this medicine at 2–8°C (36–46°F) in the original carton to protect it from light. There are several certified and genuine suppliers of Brentuximab Vedotin, if you want to buy Adcetris injection in India, contact toll-free no. 18008891064
Source - https://namepatientprogram.blogspot.com/2022/07/adcetris-encapsulatedinformation.html